Journal: European Journal of Medical Research
Article Title: Mechanism of ultrasound-guided renal parenchymal injection of MSCs for the treatment of chronic kidney disease: down-regulated SGK1 promotes M2 macrophage polarization
doi: 10.1186/s40001-025-03724-8
Figure Lengend Snippet: Bioinformatics analysis and Western blot confirm that SGK1 is a downstream target gene for MSCs in the treatment of renal fibrosis. A Correlation analysis revealed the values of 9 samples. B Volcano plot showing the DEGs in the CKD models relative to the controls, with red dots representing significantly upregulated genes and blue dots indicating downregulated genes. C , D GO enrichment analysis of these DEGs was performed to identify enriched molecular functions, biological processes, and cellular components. E Heatmap showing the DEGs asscociated with immune modulation. F Western blotting detection of the protein levels of SGK1, LTB4R2, SH2D1B, and MAP3K6 in rat renal tissues from the Control group, CKD group, and Treatment group. G Western blotting detection of the protein levels of SGK1, LTB4R2, SH2D1B, and MAP3K6 in HK-2 cells treated with TGF-β1 and MSCs. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: Human umbilical cord MSCs (MEISEN, CTCC-159-HUM), human acute monocytic leukemia cell line THP-1 (MEISEN, CTCC-001-0044) and human renal tubular epithelial cell line HK-2 cells (ATCC, CRL-2190) were cultured in DMEM (Gibco, 11,965–092) with 10% fetal bovine serum (FBS; Gibco, 10,099–141) and 1% penicillin–streptomycin (Gibco, 15,140-122).
Techniques: Western Blot, Control